Views & Analysis A world leader in genomics, but England’s patients face obst... England is at the forefront of the genomics revolution – but NHS patients are unlikely to be the first to benefit.
News Health firms should prepare for Amazon move, says J&J chief Johnson & Johnson’s CEO Alex Gorsky says he would welcome the disruptive influence of Amazon should it decide to move into healthcare.
News A Pfizer consumer buyout won't detract from pharma business,... Walmsley has axed 40% of management team in shake-up
News Bad week for dementia R&D after Axovant howler and another f... Axovant misreports trial results, Lundbeck Alzheimer's drug fails
News Akebia joins GSK in US market for oral CKD anaemia drugs The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS
Digital Sponsored Innovation as Strategy: Enabling life sciences of the future Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences.